prednisone has been researched along with fluorodeoxyglucose f18 in 188 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (1.60) | 18.2507 |
| 2000's | 38 (20.21) | 29.6817 |
| 2010's | 117 (62.23) | 24.3611 |
| 2020's | 30 (15.96) | 2.80 |
| Authors | Studies |
|---|---|
| Fischman, AJ; Palmer, WE; Polisson, RP; Rosenthal, DI; Rubin, RH; Schoenberg, OI; Simon, LS | 1 |
| Fischman, A; Palmer, WE; Polisson, RP; Rosenthal, D; Rubin, R; Schoenberg, OI; Simon, LS | 1 |
| Golding, R; Hoekstra, OS; Ossenkoppele, GJ; Teule, GJ; van Lingen, A | 1 |
| Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Weihrauch, MR; Wolf, J | 1 |
| Comans, EF; Hoekstra, OS; Huijgens, PC; Jonkhoff, AR; Lammertsma, AA; Raijmakers, PG; Teule, GJ; v Tinteren, H; van der Hoeven, JJ; Zijlstra, JM | 1 |
| Bleeker-Rovers, CP; Bredie, SJ; Corstens, FH; Oyen, WJ; van der Meer, JW | 2 |
| Fujita, K; Hoshino, A; Itoh, K; Kawada, E; Kogure, T; Mantani, N; Sakamoto, H; Tamura, J; Ukita, T | 1 |
| Espinola, D; Fletcher, TM | 1 |
| Choi, SJ; Kim, HT; Park, YH; Ryoo, BY | 1 |
| Kawai, N; Kawanishi, M; Nagao, S; Tamiya, T | 1 |
| Bar-Shalom, R; Eilam, O; Hamoud, S; Hayek, T; Rozin, A; Zalts, R | 1 |
| Bibb, J; Hromas, R; Rabinowitz, I | 1 |
| Gibbs, SD; Gill, SI; Hicks, RJ; Seymour, JF | 1 |
| Bar-Shalom, R; Jacob, G; Rozin, AP; Strizevsky, A | 1 |
| Kawai, N; Miyake, K; Nagao, S; Nishiyama, Y; Tamiya, T | 1 |
| Jacobs, A; Root, J; Van Gorp, W | 1 |
| Hachulla, E; Hatron, PY; Huglo, D; Lambert, M; Launay, D; Lavogiez, C; Quéméneur, T; Queyrel, V; Steinling, M | 1 |
| Kanenishi, K; Komoto, D; Monden, T; Nishiyama, Y; Ohkawa, M; Ohno, M; Sasakawa, Y; Satoh, K; Toyama, Y; Yamamoto, Y | 1 |
| Hoffmann, U; Tatò, F; Weiss, M | 1 |
| Adler, BH; Binkovitz, LA; Nicol, KK; Rennebohm, RM; Young, AS | 1 |
| Atasever, T; Chandramouly, A; Christos, P; Coleman, M; Furman, RR; Goldsmith, SJ; Kostakoglu, L; Kothari, P; Leonard, JP; Verma, S | 1 |
| Haba, R; Kawai, N; Kushida, Y; Miyake, K; Nagao, S; Nishiyama, Y; Sasakawa, Y; Tamiya, T; Yamamoto, Y | 1 |
| Akdemir, UO; Benekli, M; Buyukberber, S; Coskun, U; Kapucu, O; Kaya, AO; Yildiz, R | 1 |
| Inoue, Y; Iwasaki, H; Nakatsuka, S; Soma, T; Tamaki, H; Yamagami, T | 1 |
| Arsos, G; Baarslag, HJ; de Klerk, JM; Weijs, LE; Wittebol, S | 1 |
| Halkar, RK; Kost, CB; Reilly, TB; Schuster, DM; Starsiak, MD | 1 |
| Aupérin, A; Bonniaud, G; Bosq, J; Couanet, D; Edeline, V; Fermé, C; Leboulleux, S; Lumbroso, J; Masson, F; Pigneur, F; Ribrag, V; Schlumberger, M; Vanel, D | 1 |
| Amrein, PC; Hales, CA; Kradin, RL; Meyer, GS; Sharma, A | 1 |
| Mortelmans, L; Moulin-Romsee, G; Spaepen, K; Stroobants, S | 1 |
| Minato, M; Takahashi, T; Tsujisaki, M; Tsukuda, H; Yoshimoto, M | 1 |
| Amthauer, H; Bares, R; Bockisch, A; Borchmann, P; Diehl, V; Dietlein, M; Eich, HT; Engert, A; Franklin, J; Fuchs, M; Klutmann, S; Knapp, WH; Kobe, C; Lohri, A; Lorenz, R; Markova, J; Mueller, RP; Schicha, H; Schreckenberger, M; Weckesser, M; Zijlstra, JM | 1 |
| Escalón, MP; Han, HS; Hsiao, B; Lossos, IS; Serafini, A | 1 |
| Daimaru, O; Fukaya, N; Imai, T; Ito, S; Nagata, T; Uchida, H; Yamane, T; Yoshiya, K | 1 |
| Gurbuxani, S; Kircher, SM; Smith, SM | 2 |
| Belhadj, K; Copie-Bergman, C; Dupuis, J; El Gnaoui, T; Gaillard, I; Gisselbrecht, C; Haioun, C; Hemery, F; Itti, E; Kuhnowski, F; Lin, C; Meignan, M; Rahmouni, A | 1 |
| Dedeckova, K; Dietlein, M; Eich, HT; Engert, A; Klaskova, K; Kobe, C; Kozak, T; Markova, J; Plütschow, A; Skopalova, M | 1 |
| Chu, J; Kok, J; Lin, M; Lin, P; Patapanian, H; Shingde, M | 1 |
| Endo, K; Higuchi, T; Kuji, I; Matsuda, H; Murakami, K; Nakajima, K; Oriuchi, N; Tsukamoto, N | 1 |
| Akpinar, T; Aydin, O; Baran, I; Bicer, M; Gullulu, S; Kaderli, AA; Ozkalemkas, F; Yesilbursa, D | 1 |
| Advani, R; Gascoyne, R; Horning, SJ; Juweid, ME; McMillan, A; Quon, A; Schöder, H; Swinnen, LJ; Wiseman, G | 1 |
| Berthou, C; Boisramé, S; Ianotto, JC; Querellou, S; Tempescul, A; Valette, G | 1 |
| Agostinelli, C; Baccarani, M; Broccoli, A; Castellucci, P; Derenzini, E; Fanti, S; Fina, MP; Gandolfi, L; Lopci, E; Pellegrini, C; Pileri, S; Stefoni, V; Venturini, F; Zinzani, PL | 1 |
| Kuruvilla, J | 1 |
| Carrasquillo, JA; Dunleavy, K; Grant, N; Jaffe, ES; Little, RF; Pittaluga, S; Steinberg, SM; Wayne, AS; Wilson, WH; Yarchoan, R | 1 |
| Qiao, W; Wang, C; Wang, T; Xing, Y; Zhao, J | 1 |
| Chihara, D; Ine, S; Kagami, Y; Kato, H; Morishima, Y; Oki, Y; Onoda, H; Taji, H; Yamamoto, K | 1 |
| Caravelli, JF; Filippa, DA; Hamlin, PA; Horwitz, S; Iasonos, A; Meikle, JL; Moskowitz, CH; Noy, A; O'Connor, OA; Palomba, ML; Portlock, CS; Schöder, H; Sima, C; Straus, D; Teruya-Feldstein, J; Weaver, SA; Zelenetz, AD | 1 |
| Edet-Samson, A; Lahaxe, L; Marie, I; Vera, P | 1 |
| Britton, KA; Katz, JT; Levy, BD; Loscalzo, J; Stevenson, WG | 1 |
| Blouet, A; Courbon, F; David, I; Filleron, T; Izar, F; Laprie, A; Metwally, H; Plat, G; Rives, M; Robert, A; Vial, J; Zerdoud, S | 1 |
| Gallamini, A; Grimaldi, F; Nicolai, E; Pane, F; Picardi, M; Soricelli, A | 1 |
| Ananthasivan, R; Chandra, S; Kavindran, R; Seshadri, N; Srikanth, G | 1 |
| Argnani, L; Baccarani, M; Broccoli, A; Derenzini, E; Fanti, S; Gandolfi, L; Pellegrini, C; Quirini, F; Stefoni, V; Zinzani, PL | 1 |
| Amoura, Z; André, M; Aumaître, O; Charlotte, F; Grimon, G; Guettrot-Imbert, G; Haroche, J; Kelly, A; Ninet, J; Possenti, S | 1 |
| Bartlett, NL; Cashen, AF; Dehdashti, F; Homb, A; Luo, J; Siegel, BA | 1 |
| Babb, A; Macdonald, D; Naresh, KN; Zerizer, I | 1 |
| Bardet, S; Berriolo-Riedinger, A; Bologna, S; Brière, J; Casasnovas, RO; Coiffier, B; Haioun, C; Jais, JP; Julian, A; Meignan, M; Morschhauser, F; Thieblemont, C; Vera, P | 1 |
| Böll, B; Dedeckova, K; Dietlein, M; Eich, HT; Kahraman, D; Klaskova, K; Kobe, C; Kozak, T; Markova, J; Mocikova, H; Skopalova, M | 1 |
| Ambrogi, V; Cavalieri, E; Cox, MC; Lanni, V; Marchetti, P; Monarca, B; Pelliccia, S; Scopinaro, F; Spiriti, MA | 1 |
| Cho, SB; Kim, JS; Lee, JH; Lee, SH; Zheng, Z | 1 |
| Arabi, M; Dvorak, R; Gross, MD; Kujawski, L; Smith, LB | 1 |
| Fisher, DC; Hornick, JL; Jagannathan, JP; Krajewski, KM; O'Regan, K; Ramaiya, N; Saboo, SS | 1 |
| Dickinson, KK; McWilliams, ET; Raman, V; Walker, DM | 1 |
| Ardeshna, K; D'Sa, S; Marzolini, M; Padhani, A; Wong, WL | 1 |
| Fujitani, Y; Inaba, A; Kosaka, S; Ohta, K; Okamura, T; Senzaki, H; Takeoka, Y; Yamamura, R | 1 |
| Bellò, M; Bisi, G; Botto, B; Chiappella, A; Ferrero, S; Franceschetti, S; Giunta, F; Ladetto, M; Limerutti, G; Menga, M; Nicolosi, M; Passera, R; Pregno, P; Priolo, G; Puccini, B; Rigacci, L; Salvi, F; Vaggelli, L; Vitolo, U | 1 |
| Codreanu, I; Dasanu, CA; Divgi, C; Weinstein, GS | 1 |
| Beyne-Rauzy, O; Brechemier, D; Dugert, E; Hitzel, A; Julian, A; Le Guellec, S; Wagner, T | 1 |
| Escobar, H; Folkens, JU; Hoffmann, R; Kontny, U; Pohl, M; van Buiren, M; Wild, D; Yoshimi, A | 1 |
| Catalano, PJ; Halasz, LM; Jacene, HA; Lacasce, A; Mauch, PM; Ng, AK; Van den Abbeele, AD | 1 |
| Dewar, R; Freedman, AS; Giardino, AA; Mauch, P; Ramaiya, NH; Shinagare, AB; Shinagare, SA; Weckstein, D | 1 |
| Ahn, HK; Cho, SH; Choi, JY; Hwang, DW; Ji, JH; Kim, SJ; Kim, WS; Lee, JY; Maeng, CH; Moon, SH; Park, LC; Park, S | 1 |
| Dai, BL; Ling, L; Luo, XM; Luo, YZ; Wang, QY; Yan, SX; Zhao, K; Zhou, SH | 1 |
| Berenger, N; Berriolo-Riedinger, A; Brice, P; Casasnovas, RO; Colombat, P; Dupuis, J; Feugier, P; Gallamini, A; Haioun, C; Julian, A; Laurent, G; Meignan, M; Mounier, N; Paone, G; Salles, G; Soubeyran, P; Tilly, H; Tychyj-Pinel, C; Vera, P; Xerri, L | 1 |
| de Jong, WK; Groen, HM; Kluin, PM | 1 |
| Ahn, JS; Bom, HS; Byun, BH; Chae, YS; Jung, SH; Kim, HJ; Kim, HW; Kim, YK; Kweon, SS; Lee, JJ; Lee, SW; Min, JJ; Sohn, SK; Yang, DH | 1 |
| Delwail, V; Diviné, M; Guilhot, F; Perdrisot, R; Puyade, M; Tomowiak, C; Yacoub, M | 1 |
| Burger, IA; Goldman, DA; Gonen, M; Hricak, H; Kumar, A; Schöder, H; Vargas, HA; Zelenetz, AD | 1 |
| Chung, JS; Lee, GW; Lee, HS; Lee, SE; Lee, SM; Oh, MY; Shin, HJ; Song, MK | 1 |
| Avivi, I; Bar-Shalom, R; Dann, EJ; Faibish, T; Leiba, R; Rowe, JM; Zilberlicht, A | 1 |
| Arcaini, L; Biasoli, I; Boccomini, C; Carella, AM; D'Arco, AM; Di Raimondo, F; Federico, M; Ferreri, AJ; Gaidano, G; Gallamini, A; Luminari, S; Mastronardi, S; Merli, F; Musto, P; Rusconi, C; Santoro, A; Spina, M; Versari, A; Zinzani, PL | 1 |
| Hakman, P; Nowak, A; Vallelian, F | 1 |
| Bernard, F; Bernit, E; Berthelot, JM; Colavolpe, C; Costedoat-Chalumeau, N; Ebbo, M; Gobert, D; Godeau, B; Grados, A; Guedj, E; Hamidou, M; Harlé, JR; Haroche, J; Lifermann, F; Mariette, X; Masseau, A; Morel, N; Palat, S; Papo, T; Schleinitz, N; Zaidan, M | 1 |
| Bargay, J; Bello, JL; Caballero, D; Canales, M; Cortés, M; Donato, E; Ferrer, S; González-Barca, E; Oriol, A; Salar, A; Sánchez, JJ; Tomás, JF; Vidal, MJ | 1 |
| Choi, JY; Hong, JY; Jung, CW; Kim, HJ; Kim, SJ; Kim, WS; Ko, YH | 1 |
| Adeli, A; Drubach, DA; Machulda, MM | 1 |
| Bahlis, NJ; Bence-Bruckler, I; Duggan, P; Kloiber, R; Mansoor, A; Owen, C; Stewart, DA | 1 |
| Amitani, R; Ariyasu, R; Hanaoka, K; Inada, S; Konishi, Y; Nagano, H; Nakagawa, K; Nakamura, Y; Nishizaka, Y; Okamoto, N; Taki, M; Tsudo, M; Wakasa, T; Wakayama, T; Yoshida, M; Yoshimura, C | 1 |
| Capacchione, D; Gallicchio, R; Gattozzi, D; Guariglia, R; Mansueto, G; Musto, P; Nardelli, A; Pedicini, P; Simeon, V; Soscia, E; Storto, G | 1 |
| Avigdor, A; Avivi, I; Benyamini, N; Davidson, T; Goshen, E; Kedmi, M; Nagler, A; Ribakovsky, E; Tadmor, T | 1 |
| Bodell, MA; Kraus, ES; Lipson, EJ; Sharfman, WH | 1 |
| Apter, S; Avigdor, A; Ben-Bassat, I; Berkowicz, M; Davidovitz, Y; Davidson, T; Goshen, E; Kedmi, M; Kneller, A; Merkel, D; Nagler, A; Ribakovsy, E; Shimoni, A; Sirotkin, T; Volchek, Y | 1 |
| Buck, AK; Herrmann, K; Knott, M; Lapa, C; Rasche, L; Rosenwald, A | 1 |
| Arzu, I; Dabaja, BS; Fayad, LE; Hagemeister, FB; Hess, K; Kedir, A; Mawlawi, O; Medeiros, LJ; Oki, Y; Podoloff, DA; Reed, VK; Rodriguez, A; Shihadeh, F; Wogan, CF | 1 |
| Balzarotti, M; Brusamolino, E; Cabras, MG; Cavalli, F; Ceriani, L; Davies, A; Ferreri, AJ; Finolezzi, E; Giovanella, L; Johnson, PW; Lopez-Guillermo, A; Martelli, M; Montoto, S; Pileri, SA; Rigacci, L; Salvi, F; Stelitano, C; Vitolo, U; Zinzani, PL; Zucca, E | 1 |
| Amthauer, H; Bockisch, A; Borchmann, P; Diehl, V; Dietlein, M; Drzezga, A; Eich, HT; Engert, A; Franke, M; Fuchs, M; Haverkamp, H; Kahraman, D; Kluge, R; Klutmann, S; Kobe, C; Kuhnert, G; Maintz, D; Persigehl, T; Wolf, HH | 1 |
| Dastidar, P; Eskola, H; Järvenpää, R; Kellokumpu-Lehtinen, PL; Korkola, P; Pertovaara, H; Vornanen, M; Wu, X | 1 |
| Ikebe, D; Ise, M; Itami, M; Iwata, S; Kumagai, K; Miyaki, T; Sugawara, T; Tsujimura, H; Yamada, S; Yonemoto, T | 1 |
| Arranz, R; Bargay, J; Bello, JL; Caballero, MD; Conde, E; Coronado, M; González-Barca, E; Grande, C; Hernández, MT; Marín-Niebla, A; Martín, A; Montes-Moreno, S; Panizo, C; Pardal, E; Pérez-Ceballos, E | 1 |
| Fujiwara, Y; Ikegaya, S; Kimura, H; Kishi, S; Okazawa, H; Tsuchida, T; Tsuji, K; Ueda, T; Urasaki, Y; Yamauchi, T | 1 |
| Chekol, S; Chong, EA; Glatstein, E; Nagle, SJ; Nasta, SD; Plastaras, JP; Schuster, SJ; Shah, NN; Svoboda, J; Torigian, DA | 1 |
| Castillo, JJ; Reagan, JL; Sikov, WM; Winer, ES | 1 |
| Doshi, JA; Huntington, SF; Nasta, SD; Schuster, SJ; Svoboda, J | 1 |
| Kumar, S; Morales, F; Vega, RM | 1 |
| Chung, JS; Kim, SJ; Kim, SS; Shin, HJ; Song, MK | 1 |
| Advani, RH; Gascoyne, R; Habermann, TM; Hong, F; Horning, SJ; Kahl, BS; Li, H; Quon, A; Ranheim, EA; Swinnen, LJ | 1 |
| Adams, HJ; Kwee, TC; Nievelstein, RA | 1 |
| Baues, C; Dietlein, M; Eich, HT; Engenhart-Cabillic, R; Engert, A; Haverkamp, H; Haverkamp, U; Hegerfeld, K; Herfarth, K; Kobe, C; Kriz, J; Kuhnert, G; Lukas, P; Reinartz, G; Schmidberger, H; Staar, S | 1 |
| Ahmed, MA; Ahmed, S; Chuang, HH; Costelloe, C; Dabaja, B; Davis, RE; Fanale, MA; Fayad, L; Fowler, N; Hagemeister, FB; Khouri, IF; Medeiros, LJ; Nastoupil, L; Neelapu, S; Nieto, Y; Oki, Y; Pinnix, CC; Reed, V; Rodriguez, MA; Romaguera, JE; Turturro, F; Westin, J; Wogan, CF | 1 |
| Bargetzi, M; Biaggi, C; Dirnhofer, S; Driessen, C; Gigli, F; Hany, T; Hitz, F; Klingbiel, D; Krasniqi, F; Mamot, C; Martinelli, G; Mey, U; Pabst, T; Pless, M; Renner, C; Rusterholz, C; Samarin, A; Zucca, E | 1 |
| Advani, RH; Binkley, MS; Hiniker, SM; Hoppe, RT; Mittra, ES; Natkunam, Y; Wu, S | 1 |
| Nguyen, TT; Parker, BJ; Yachoui, R | 1 |
| Alzahrani, M; Connors, JM; de Nully Brown, P; El-Galaly, TC; Hansen, JW; Hutchings, M; Iyer, V; Johnsen, HE; Loft, A; Savage, KJ; Sehn, LH; Villa, D; Wilson, D | 1 |
| Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Heggelman, BG; Kwee, TC; Nievelstein, RA | 1 |
| Fan, Y; Song, Y; Wang, X; Yang, Z; Ying, Z; Zhang, Y; Zhu, J | 1 |
| Apel, A; Avigdor, A; Ben-Bassat, I; Dann, EJ; Davidson, T; Kedmi, M; Levi, I; Nagler, A; Polliack, A | 1 |
| Ahlman, MA; Grayson, PC; Hughes, M; Malayeri, AA; Newman, KA; Pratt, D | 1 |
| Duan, L; Li, J; Qiu, H; Tian, T; Wang, D; Wang, J; Zhang, Q; Zhang, X | 1 |
| Barr, PM; Bartlett, NL; Cheson, BD; Cook, JR; Evens, AM; Fanale, MA; Fisher, RI; Friedberg, JW; Gascoyne, RD; Hsi, ED; Kahl, BS; Knopp, MV; LaCasce, AS; LeBlanc, M; Lechowicz, MJ; Leonard, JP; Li, H; Mittra, ES; Moskowitz, CH; Noy, A; Press, OW; Rimsza, LM; Schöder, H; Straus, DJ; Sweetenham, JW | 1 |
| Kok, TY; Neo, SH; Tong, AK | 1 |
| Esbah, AÜ; Esbah, O; Öneç, B; Öneç, K | 1 |
| Awan, UK; Bashir, H; Basit, A; Hameed, A; Khan, SA; Muzaffar, N; Siddiqui, N | 1 |
| Bellò, M; Bisi, G; Caracciolo, D; Chiappella, A; Filippi, AR; Levis, M; Piva, C; Ricardi, U; Vitolo, U | 1 |
| Higo, T; Ikeda, S; Ohtani, K; Uwatoku, T | 1 |
| Chen, F; Chen, Y; Fang, Y; Han, X; Huang, H; Liu, J; Liu, Q; Ni, B; Shen, L; Shi, Y; Wang, J; Wang, T; Xiao, F; Xu, L; Zhang, M; Zheng, L; Zhong, H; Zhong, L; Zhu, J | 1 |
| Coutinho, AM; de Oliveira Costa, R; de Paula, HM; Hallack Neto, A; Lage, LA; Pereira, J; Siqueira, S | 1 |
| Gergely, L; Illés, Á | 1 |
| Adams, HJ; Kwee, TC | 1 |
| Chen, Y; Huang, G; Huang, H; Liu, J; Zhou, M; Zhou, X | 1 |
| Balzarotti, M; Cabrera, ME; Ceriani, L; Chiappella, A; Cunningham, D; Ferreri, AJ; Giovanella, L; Gospodarowicz, MK; Guarini, A; Johnson, PW; Martelli, M; Ricardi, U; Stelitano, C; Zinzani, PL; Zucca, E | 1 |
| Cheson, BD; Kostakoglu, L | 1 |
| Butcher, B; Chong, G; Cull, G; Fay, K; Filshie, R; Gandhi, MK; Gill, D; Grigg, A; Hahn, U; Hertzberg, M; Hicks, RJ; Ho, SJ; Hofman, MS; Johnston, A; Kannourakis, G; Lewis, ID; Milliken, S; Renwick, W; Seymour, JF; Taper, J; Trotman, J; Warburton, P; Watson, AM; Wirth, A | 1 |
| Kong, L; Shi, F; Zhang, NS; Zhu, H | 1 |
| Aouba, A; Bienvenu, B; Boutemy, J; de Boysson, H; Dumont, A; Lambert, M; Liozon, E; Ly, KH; Maigné, G; Manrique, A; Martin Silva, N | 1 |
| Avivi, I; Bar-Shalom, R; Benyamini, N; Dann, EJ; Farbstein, D; Lavi, N; Shapira, G; Zilberlicht, A | 1 |
| Kim, J; Kim, SE; Lee, JS; Lee, WW; Song, YS | 1 |
| Bairey, O; Berger, T; Cohen, YC; Eshel, L; Raanani, P; Shpilberg, O; Stern, D | 1 |
| Delmer, A; Dupuis, J; Durot, E; Godet, S; Hivert, B; Ivanoff, S; Kanagaratnam, L; Le Dû, K; Leblond, V; Lemal, R; Leprêtre, S; Merabet, F; Michallet, AS; Morel, P; Perrot, A; Regny, C; Roussel, X; Sutton, L; Tomowiak, C; Toussaint, E; Van Den Neste, E; Zini, JM | 1 |
| Gou, Z; Zhao, Y; Zhou, J | 1 |
| Demir, E; Karaoglan, C; Sair, B; Sever, MS; Turkmen, A; Yazici, H; Yegen, G | 1 |
| Behringer, D; Bengel, FM; Berdel, WE; Bernhard, H; Bockisch, A; Brink, I; Brinkmann, M; Dührsen, U; Dürig, J; Franzius, C; Freesmeyer, M; Gaska, T; Geworski, L; Giagounidis, A; Griesshammer, M; Haberkorn, U; Hertel, A; Hertenstein, B; Hoelzer, D; Höffkes, HG; Holzinger, J; Hüttmann, A; Jöckel, KH; Klapper, W; Kofahl-Krause, D; Kotzerke, J; Krohn, T; Kroschinsky, F; Kurch, L; La Rosée, P; Maschmeyer, G; Matschke, J; Mesters, R; Müller, S; Ose, C; Pöppel, T; Prange-Krex, G; Raghavachar, A; Rekowski, J; Scherag, A; Schmitz, C; Thomssen, H; van Assema, DME; Weckesser, M; Wilop, S | 1 |
| Abid, MB; Chan, EHL; de Mel, S; Loi, HY; Poon, LM; Wang, S | 1 |
| Bahar, S; Dal, T | 1 |
| Diamond, T; Kumar, S | 1 |
| Alashkar, F; Behringer, D; Bengel, FM; Bernhard, H; Brink, I; Brinkmann, M; Dienst, A; Dührsen, U; Dürig, J; Franzius, C; Freesmeyer, M; Ganser, A; Gaska, T; Giagounidis, A; Griesshammer, M; Grube, M; Hahn, D; Hautzel, H; Hertel, A; Hertenstein, B; Hoelzer, D; Höffkes, HG; Höhler, T; Holzinger, J; Hüttmann, A; Jöckel, KH; Klapper, W; Klein, A; Kotzerke, J; Krohn, T; Kroschinsky, F; Kurch, L; La Rosée, P; Marienhagen, J; Maschmeyer, G; Mesters, R; Müller, SP; Naumann, R; Nückel, H; Ose, C; Pöpperl, G; Prange-Krex, G; Raghavachar, A; Rekowski, J; Römer, W; Schmitz, C; Schroers, R; Schütte, J; Schwarzer, A; Steiniger, H; Südhoff, T; Weckesser, M; Wilop, S | 1 |
| Bantilan, K; Horwitz, SM; Ito, K; Mehta-Shah, N; Moskowitz, AJ; Sauter, C; Schöder, H | 1 |
| Cui, Z; Dong, C; Han, Y; Huang, L; Li, J; Liu, J; Ren, Y | 1 |
| Flowers, CR; Goldstein, J; Islam, P | 1 |
| Bolzacchini, E; Campiotti, L; Casagrande, S; DE Palma, D; Guasti, L; Ogliari, F; Proserpio, I; Schiorlin, I; Squizzato, A; Suter, M | 1 |
| Fowler, M; Guo, HH; Iagaru, A; Mittra, E; Ning, N; Witteles, R | 1 |
| Fahad, F; Saad Shaukat, MH; Torosoff, M; Weinreb, D | 1 |
| Ahmed, S; Aleman, BMP; Andraos, TY; Balogh, A; Binkley, MS; Brady, JL; Bratman, SV; Chau, K; Chelius, M; Choi, SH; Constine, LS; Dabaja, B; Eich, HT; El-Galaly, TC; Filippi, AR; Hajj, C; Hardy, S; Hodgson, DC; Hoppe, RT; Jones, M; Kirova, YM; Levis, M; MacManus, M; Mikhaeel, NG; Ng, AK; Oguchi, M; Reinartz, G; Ricardi, U; Suh, CO; Vistisen, AK; Wirth, A; Yahalom, J | 1 |
| Cartenì, G; Fusco, M; Pirozzi, A; Riccardi, F; Scagliarini, S | 1 |
| Dierickx, D; Gheysens, O; Goffin, K; Laenen, A; Tousseyn, T; Van Keerberghen, CA; Vandenberghe, P; Vergote, V; Verhoef, G | 1 |
| Cheng, W; Hou, G; Jiang, Y | 1 |
| Benn, BS; De Marco, T; Gerstenfeld, EP; Hsia, HH; Janmohamed, M; Klein, L; Koth, LL; Lee, BK; Moss, JD; Murray, TO; Pampaloni, MH; Parwani, P; Petek, BJ; Rosenthal, DG; Scheinman, MM; Selby, V; Vedantham, V; Zikherman, J | 1 |
| Chung, MJ; Eom, KY; Kim, JH; Kim, WC; Lee, JH; Lee, JW; Oh, D | 1 |
| Fukumi, T; Ishikawa, T; Makita, M; Moriyama, T; Murakami, H; Nagakita, K; Shinno, Y; Sunami, K; Yoshioka, T | 1 |
| Chen, EH; Chrispin, J; Gilotra, NA; Griffin, JM; Kasper, EK; Okada, DR; Saad, E; Solnes, LB; Tandri, H; Wand, AL | 1 |
| Cho, BS; Cho, SG; Eom, KS; Jeon, YW; Kim, DW; Kim, HJ; Kim, YJ; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, GJ; Park, SS; Shin, SH; Yahng, SA; Yoon, JH | 1 |
| Bartlett, NL; Cheson, BD; Friedberg, JW; Hall, N; Higley, HR; Hsi, ED; Kahl, BS; Kelloff, G; Knopp, MV; Kostakoglu, L; Leonard, JP; Liu, H; Polley, MC; Schöder, H; Schwartz, LH; Wagner-Johnston, N; Wilson, WH; Zelenetz, AD; Zhang, J | 1 |
| Cho, SY; Jadvar, H; Kim, CK; Potvin, K; Winquist, E; Zukotynski, KA | 1 |
| Ardeshna, KM; Barrington, SF; Clifton-Hadley, L; Counsell, N; Cunningham, D; Lawrie, A; McMillan, A; Mikhaeel, NG; O'Doherty, MJ; Radford, JA; Smith, P | 1 |
| Do, YR; Kim, DS; Kim, JS; Kim, SJ; Koh, Y; Lee, HS; Lee, WS; Moon, JH; Oh, SY; Park, Y; Shin, HJ; Song, GY; Yang, DH; Yhim, HY; Yoon, SE | 1 |
| Kang, L; Su, T; Wang, H; Wang, S; Yang, L | 1 |
| Aquino-Parsons, C; Bénard, F; Brown, MJ; Connors, JM; Farinha, P; Freeman, CL; Gerrie, AS; Lo, A; Morris, J; Pickles, T; Savage, KJ; Scott, DW; Sehn, LH; Skinnider, B; Slack, GW; Srour, L; Tonseth, P; Villa, DR; Wilson, DC | 1 |
| Giraud, N; Prati, C; Verhoeven, F; Wendling, D | 1 |
| El Khoury, M; Lalonde, L; Maietta, A; Mesurolle, B; Tran, A; Trop, I | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Lee, KH; Lim, CH | 1 |
| Berlangieri, S; Chong, G; Fancourt, T; Hannah, A; Hawkes, E; Lee, ST; Leung, T; Shen, E; Wai, SH; Wight, J | 1 |
| Pettitt, AR; Trotman, J | 1 |
| Lancellotti, P; Matsuyama, E; Mitamura, H; Nagatomo, Y; Tsugu, T | 1 |
| Bai, Y; Li, D; Li, X; Liang, L; Zhang, R | 1 |
| Carvalho, IP; Esteves, S; Freitas, AC; Gomes da Silva, M; Salgado, L | 1 |
| Bruno, A; Cascione, L; Ceriani, L; Chauvie, S; Dalmasso, F; Dirnhofer, S; Esposito, F; Giovanella, L; Gritti, G; Hayoz, S; Mamot, C; Milan, L; Pirosa, MC; Rambaldi, A; Schär, S; Zucca, E | 1 |
| Bento-Miranda, M; Figueiredo, P; Gravito-Soares, E; Gravito-Soares, M; João, M | 1 |
| Cao, J; Hong, X; Ji, D; Jiang, J; Liu, L; Liu, X; Liu, Y; Lv, F; Song, S; Wang, Z; Xia, Z; Yu, B; Zhang, Q | 1 |
| Cao, J; Gu, JJ; Guo, Y; Hong, X; Ji, D; Jin, J; Liu, Y; Lv, F; Xia, Z; Xue, K; Zhang, Q | 1 |
| Dührsen, U; Fendler, WP; Ferdinandus, J; Hanoun, C; Herrmann, K; Hüttmann, A; Kersting, D; Rahbar, K; Reinhardt, HC; Rischpler, C; Sandach, P; Schäfers, M; Seifert, R; Umutlu, L; von Tresckow, B; Weckesser, M | 1 |
| Chang, Y; Li, F; Sun, Y; Wang, N; Wang, R; Zhu, H | 1 |
| Adams, SL; Bhattaru, A; Bravo, PE; Clancy, CB; Dubroff, J; Goldberg, L; Jean, C; Marchlinski, FE; Patel, V; Patterson, K; Peyster, E; Rojulpote, C; Rossman, M; Selvaraj, S; Vidula, MK | 1 |
| Akdim, F; Grutters, JC; Keijsers, RGM; Mathijssen, H; Post, MC; van de Garde, EMW; Veltkamp, M; Vis, R | 1 |
| Chen, YJ; Hsieh, CH; Huang, YM; Lee, JC; Tsao, CH; Wang, SY | 1 |
| Birnie, DH; Culver, DA; De Bortoli, A; Kron, J; Lehtonen, J; Murgatroyd, F; Nagai, T; Nery, PB | 1 |
| Arment, C; Bois, J; Castrichini, M; Churchill, R; Elwazir, M; Myasoedova, E; Rosenbaum, A; Sykora, D; Young, K | 1 |
| Benz, RM; Betz, MJ; Beuschlein, F; Bieri, O; Chirindel, A; Fischer, JGW; Ghosh, A; Loeliger, RC; Madoerin, P; Maushart, CI; Othman, A; Reincke, M; Senn, JR; Sun, W; Takes, M; Wild, D; Wolfrum, C; Zamboni, N; Zech, CJ | 1 |
9 review(s) available for prednisone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Standard therapy of advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2009 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Laryngeal Neoplasms; Lymphoma, B-Cell, Marginal Zone; Prednisone; Radionuclide Imaging; Treatment Outcome; Vincristine | 2012 |
Are We Missing Diagnosis of Large Vessel Vasculitis? Role of (18)F-Fluorodeoxyglucose PET-CT Scan.
Topics: Aged; Aorta, Abdominal; Aorta, Thoracic; Biopsy, Needle; C-Reactive Protein; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Angiography; Male; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Quadriplegia; Rare Diseases; Risk Assessment; Role; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Vasculitis | 2015 |
Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Prognosis; Remission Induction; Rituximab; Treatment Outcome; Vincristine | 2015 |
Bone and bone marrow involvement in sarcoidosis.
Topics: Adult; Biopsy; Bone Diseases; Bone Marrow; Bone Marrow Diseases; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Humerus; Hydroxychloroquine; Ilium; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Patella; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Whole Body Imaging | 2015 |
[Recent advances in the understanding and treatment of diffuse large B-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Molecular Targeted Therapy; Mutation; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine | 2016 |
Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: Systematic review and meta-analysis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Vincristine | 2016 |
FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine | 2017 |
Diffuse large B cell lymphoma in a preceding IgG4-related disease with kidney restricted lambda light chain expression: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunoglobulin lambda-Chains; Immunosuppressive Agents; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Missed Diagnosis; Nephritis, Interstitial; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Renal Insufficiency, Chronic | 2020 |
26 trial(s) available for prednisone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Evaluation of tumor FDG transport and metabolism in primary central nervous system lymphoma using [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) kinetic analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Transport, Active; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kinetics; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Vincristine | 2005 |
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Radiography; Radiopharmaceuticals; Risk Factors; Survival Rate; Vincristine | 2008 |
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine; Young Adult | 2009 |
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Education, Medical, Continuing; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Nuclear Medicine; Observer Variation; Positron-Emission Tomography; Prednisone; Reproducibility of Results; Rituximab; Vincristine | 2010 |
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Child; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; HIV; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Viral Load; Young Adult | 2010 |
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prednisone; Proportional Hazards Models; Radiopharmaceuticals; Rituximab; Teniposide; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2010 |
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Rituximab; Vincristine; Vindesine | 2011 |
Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2012 |
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Italy; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Vincristine | 2013 |
Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Filgrastim; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Polyethylene Glycols; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Recombinant Proteins; Recurrence; Rituximab; Tomography, X-Ray Computed; Treatment Failure; Vincristine; Young Adult | 2013 |
Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2014 |
[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Radiopharmaceuticals; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2014 |
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Vincristine; Young Adult | 2014 |
Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Transplantation, Autologous; Treatment Outcome; Vincristine | 2014 |
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prospective Studies; Rituximab; Vincristine; Young Adult | 2015 |
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Germany; Hodgkin Disease; Humans; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Recurrence; Vincristine | 2015 |
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Vinblastine; Vincristine; Young Adult | 2016 |
Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.
Topics: Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Time Factors; Vincristine | 2016 |
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Positron-Emission Tomography; Prednisone; Retreatment; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2017 |
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine | 2018 |
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Rituximab; Survival Rate; Vincristine | 2019 |
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Progression-Free Survival; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Rituximab; Vincristine; Young Adult | 2020 |
FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Prospective Studies; Rituximab; United Kingdom; Vincristine; Young Adult | 2021 |
Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Rituximab; Vincristine | 2022 |
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine | 2022 |
Effect of high-dose glucocorticoid treatment on human brown adipose tissue activity: a randomised, double-blinded, placebo-controlled cross-over trial in healthy men.
Topics: Adipose Tissue, Brown; Calcium; Cold Temperature; Cross-Over Studies; Energy Metabolism; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Positron Emission Tomography Computed Tomography; Prednisone; Thermogenesis | 2023 |
153 other study(ies) available for prednisone and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
Topics: Acetaminophen; Adult; Aged; Arthritis, Psoriatic; Arthritis, Rheumatoid; Contrast Media; Deoxyglucose; Dextropropoxyphene; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Prednisone; Prospective Studies; Tomography, Emission-Computed; Treatment Outcome; Wrist Joint | 1995 |
Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Deoxyglucose; Dose-Response Relationship, Drug; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucocorticoids; Glucose; Humans; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Prednisone; Synovial Membrane; Tomography, Emission-Computed; Wrist Joint | 1995 |
Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxyglucose; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Monitoring, Physiologic; Prednisone; Time Factors; Tomography, Emission-Computed, Single-Photon; Vincristine | 1993 |
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Etoposide; False Negative Reactions; False Positive Reactions; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Mediastinal Neoplasms; Melphalan; Neoplasm Recurrence, Local; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Transplantation, Autologous; Vinblastine; Vincristine | 2001 |
18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine | 2003 |
Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.
Topics: Aged; Aortitis; Blood Glucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Polyarteritis Nodosa; Prednisone; Sensitivity and Specificity; Tomography, Emission-Computed; Vasculitis | 2004 |
F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Netherlands; Prednisone; Sensitivity and Specificity; Tomography, Emission-Computed; Vasculitis | 2003 |
Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biopsy; Bone Marrow; Bone Marrow Cells; Brain; Cyclophosphamide; Doxorubicin; Femur; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Humerus; Ilium; Immunophenotyping; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Prednisone; Spine; Sternum; Tomography, Emission-Computed; Vascular Neoplasms; Vincristine | 2004 |
Positron emission tomography in the diagnosis of giant cell arteritis.
Topics: Diagnosis, Differential; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Methylprednisolone; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals | 2004 |
PET imaging with F-18 fluorodeoxyglucose for primary lymphoma of bone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2005 |
Usefulness of [18F]FDG-PET kinetic analysis in non-enhancing primary central nervous system lymphoma: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kinetics; Lymphoma, B-Cell; Middle Aged; Models, Biological; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2005 |
Panaortitis: diagnosis via fluorodeoxyglucose positron emission tomography.
Topics: Aortitis; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Treatment Outcome | 2005 |
A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neck; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Thyroid Neoplasms; Vincristine | 2005 |
Primary skeletal muscle marginal zone lymphoma with persistent tissue tropism and PET-avidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Prednisone; Recurrence; Remission Induction; Sensitivity and Specificity; Vincristine | 2006 |
Fever due to aortitis.
Topics: Aged; Aorta; Aortitis; Brachiocephalic Trunk; Carotid Arteries; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Treatment Outcome | 2007 |
Isolated global amnesia associated with autoimmune thyroid disease.
Topics: Adult; Amnesia; Brain; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Thyroiditis, Autoimmune | 2006 |
[18FDG PET: a new criterion for disease activity in Takayasu arteritis].
Topics: Adult; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Takayasu Arteritis; Treatment Outcome | 2006 |
A case of non-hodgkin's lymphoma of the ovary: usefulness of 18F-FDG PET for staging and assessment of the therapeutic response.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2006 |
[Takayasu's arteritis without manifest arterial stenoses as a cause of fever of unknown origin].
Topics: Arterial Occlusive Diseases; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Takayasu Arteritis | 2006 |
Pulmonary hyalinizing granuloma and retroperitoneal fibrosis in an adolescent.
Topics: Adolescent; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Granuloma; Humans; Hyalin; Lung Diseases; Magnetic Resonance Imaging; Male; Methylprednisolone; Prednisone; Radiopharmaceuticals; Retroperitoneal Fibrosis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Iodine Radioisotopes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Retrospective Studies; Vincristine | 2006 |
FDG-PET findings of the brain in lymphomatoid granulomatosis.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphomatoid Granulomatosis; Male; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2006 |
F-18 FDG uptake due to acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient.
Topics: Acinetobacter Infections; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphoma, B-Cell; Middle Aged; Prednisone; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine | 2007 |
False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prostatic Neoplasms; Rituximab; Vincristine | 2007 |
Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cardiomegaly; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, B-Cell; Male; Pericardial Effusion; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Vincristine | 2007 |
Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Sarcoidosis; Spleen; Tomography, X-Ray Computed; Vincristine | 2007 |
Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine; Whole Body Imaging | 2008 |
Case records of the Massachusetts General Hospital. Case 26-2007 - a 61-year-old man with recurrent fevers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Duodenum; Fever; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiography; Recurrence; Renal Insufficiency; Salvage Therapy; Vascular Neoplasms; Vincristine | 2007 |
Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET.
Topics: Antineoplastic Combined Chemotherapy Protocols; Belgium; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Europe; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Vincristine | 2008 |
Successful treatment of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy and FDG-PET scan.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Cyclophosphamide; Doxorubicin; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Rituximab; Translocation, Genetic; Vincristine | 2008 |
High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Recurrence; Retrospective Studies; Rituximab; Sensitivity and Specificity; Survival Analysis; Vincristine; Young Adult | 2009 |
Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Vincristine | 2008 |
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review.
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Black or African American; Cyclophosphamide; Doxorubicin; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Male; Positron-Emission Tomography; Prednisone; Vincristine | 2007 |
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review.
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Black or African American; Cyclophosphamide; Doxorubicin; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Male; Positron-Emission Tomography; Prednisone; Vincristine | 2007 |
Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating 18fluorodeoxyglucose positron emission tomography to the International Workshop Criteria.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prospective Studies; Rituximab; Treatment Outcome; Vincristine | 2009 |
[18F]FDG PET/CT in the diagnosis of large vessel vasculitis.
Topics: Aged; Aorta; Aortitis; Blood Vessel Prosthesis Implantation; Coronary Artery Bypass; Fatal Outcome; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Postoperative Complications; Prednisone; Radiography; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
[Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Rituximab; Vinblastine; Vincristine; Young Adult | 2009 |
Diffuse involvement of the heart and great vessels in primary cardiac lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Echocardiography; Fatal Outcome; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pneumonia; Positron-Emission Tomography; Prednisone; Rituximab; Tomography, X-Ray Computed; Vincristine | 2010 |
18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Organoplatinum Compounds; Paranasal Sinus Neoplasms; Paranasal Sinuses; Positron-Emission Tomography; Prednisone; Prognosis; Remission Induction; Tomography, Emission-Computed; Vincristine | 2010 |
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Remission Induction; Retrospective Studies; Vincristine; Young Adult | 2010 |
Primary gastric diffuse large B-cell Lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scan.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hemoglobins; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Rituximab; Serum Albumin; Stomach Neoplasms; Survival Analysis; Vincristine; Young Adult | 2010 |
Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Risk Factors; Rituximab; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2010 |
Follow-up of muscular sarcoidosis using fluorodeoxyglucose positron emission tomography.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Infliximab; Male; Muscle Weakness; Muscular Diseases; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |
Clinical problem-solving. The beat goes on.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; Echocardiography; Electrocardiography; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Male; Middle Aged; Myocardium; Prednisone; Sarcoidosis; Tachycardia, Ventricular; Ventricular Dysfunction, Right | 2010 |
Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Observer Variation; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Vinblastine; Vincristine | 2011 |
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Contrast Media; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Liver; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Recurrence; Spleen; Tomography, X-Ray Computed; Young Adult | 2011 |
Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Abscess; Liver Neoplasms; Lymphoma, Large-Cell, Immunoblastic; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Remission Induction; Rituximab; Tomography, X-Ray Computed; Vincristine | 2010 |
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Monitoring, Physiologic; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Time Factors; Vincristine; Young Adult | 2011 |
F-18 FDG-PET/CT in aseptic abscesses with recurrent febrile abdominal pain.
Topics: Abdominal Abscess; Abdominal Pain; Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclophosphamide; Female; Fever; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hereditary Autoinflammatory Diseases; Humans; Immunosuppressive Agents; Liver Diseases; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Recurrence; Spleen | 2011 |
18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2011 |
Subcutaneous panniculitis-like T-cell lymphoma with extracutaneous dissemination demonstrated on FDG PET/CT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Male; Panniculitis; Positron-Emission Tomography; Prednisone; Vincristine; Young Adult | 2011 |
Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Radiopharmaceuticals; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2012 |
Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Vincristine | 2012 |
18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography in symmetrically enlarged axillary and inguinal lymph nodes of Ofuji's papuloerythroderma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Eosinophilia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Folliculitis; Groin; Humans; Immunosuppressive Agents; Lymph Nodes; Lymphadenitis; Male; Multimodal Imaging; Mycosis Fungoides; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Remission Induction; Skin Diseases, Vesiculobullous; Skin Neoplasms; Tomography, X-Ray Computed; Vincristine | 2012 |
Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Thyroid Neoplasms; Thyroiditis, Autoimmune; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2011 |
Symptomatic extranodal Rosai-Dorfman disease treated with steroids, radiation, and surgery.
Topics: Adult; Buttocks; Contrast Media; Diagnosis, Differential; Dose Fractionation, Radiation; Fluorodeoxyglucose F18; Glucocorticoids; Histiocytosis, Sinus; Humans; Immunohistochemistry; Male; Positron-Emission Tomography; Prednisone; Surgical Flaps; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome | 2011 |
Acute inflammatory aortitis: utility of hybrid imaging with positron emission tomography/computed tomography in diagnosis and follow-up.
Topics: Acute Disease; Aortitis; Azathioprine; Biopsy; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diffusion Magnetic Resonance Imaging; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2012 |
Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzopyrans; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Endometrium; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Remission Induction; Rituximab; Tomography, X-Ray Computed; Transplantation, Autologous; Vascular Neoplasms; Vincristine | 2011 |
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Young Adult | 2012 |
Fluorodeoxyglucose-induced allergic reaction: a case report.
Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Diphenhydramine; Drug Hypersensitivity; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Pyriform Sinus; Radiopharmaceuticals; Secondary Prevention; Squamous Cell Carcinoma of Head and Neck; Terfenadine; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain; Capillaries; Cognition Disorders; Cyclophosphamide; Doxorubicin; False Negative Reactions; Female; Fever; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Paresis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tissue Distribution; Tomography, X-Ray Computed; Vincristine | 2012 |
Nephrotic syndrome leading to the diagnosis of classical Hodgkin's lymphoma in a 13-year-old girl.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Mediastinal Neoplasms; Multimodal Imaging; Neoplasm Staging; Nephrotic Syndrome; Positron-Emission Tomography; Prednisone; Tomography, X-Ray Computed; Vincristine | 2012 |
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Rituximab; Treatment Failure; Vincristine; Young Adult | 2012 |
Primary bone lymphoma involving bilateral tibia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Menisci, Tibial; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Tibia; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2012 |
The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Risk; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2012 |
Overlapping immunoglobulin G4-related disease and Rosai-Dorfman disease mimicking lung cancer.
Topics: Aged, 80 and over; Autoimmune Diseases; Bronchoscopy; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Histiocytosis, Sinus; Humans; Immunoglobulin G; Kidney Diseases; Lung; Lung Neoplasms; Lymph Node Excision; Male; Positron-Emission Tomography; Prednisone; Radiography; Radiopharmaceuticals | 2012 |
Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Decision Support Techniques; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Rituximab; Tomography, X-Ray Computed; Vincristine; Young Adult | 2013 |
Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prednisone; ROC Curve; Tomography, X-Ray Computed; Vincristine | 2013 |
The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Procarbazine; Retrospective Studies; Sperm Count; Testis; Tomography, X-Ray Computed; Vinblastine; Vincristine; Young Adult | 2013 |
Prognostic value of Waldeyer's ring involvement of diffuse large B-cell lymphoma treated with R-CHOP.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Radiography; Radiopharmaceuticals; Rituximab; Survival Rate; Tumor Burden; Vincristine | 2013 |
Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Vincristine | 2013 |
[Giant cell arteritis].
Topics: Adrenal Cortex Hormones; Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prednisone; Prognosis; Risk Factors; Temporal Arteries; Ultrasonography, Doppler | 2013 |
Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Multiple Organ Failure; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Sensitivity and Specificity; Severity of Illness Index; Steroids; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pleural Effusion, Malignant; Positron-Emission Tomography; Prednisone; Republic of Korea; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2014 |
Resolution of neuropsychological and FDG-PET abnormalities in a patient with neuropsychiatric systemic lupus erythematosus.
Topics: Brain; Cerebral Cortex; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Mycophenolic Acid; Neuropsychological Tests; Positron-Emission Tomography; Prednisone; Remission Induction; Tomography, X-Ray Computed | 2013 |
Anaplastic large cell lymphoma mimicking fibrosing mediastinitis.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Diagnostic Errors; Doxorubicin; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Lymphoma, Large-Cell, Anaplastic; Mediastinitis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Sclerosis; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2013 |
F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Rituximab; Tumor Burden; Vincristine | 2014 |
Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Positron-Emission Tomography; Prednisone; Proportional Hazards Models; Retrospective Studies; Rituximab; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Autologous; Vincristine | 2014 |
Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Dacarbazine; Drug Administration Schedule; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Ipilimumab; Kidney Transplantation; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Mycophenolic Acid; Platinum Compounds; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Skin Neoplasms; Tacrolimus; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Salvage Therapy; Tomography, X-Ray Computed; Vincristine; Young Adult | 2014 |
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Leg; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2014 |
Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation.
Topics: Age Factors; Aged; Analysis of Variance; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rituximab; Sex Factors; Time Factors; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Vincristine | 2014 |
Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Vincristine | 2014 |
Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Consolidation Chemotherapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Histiocytic Sarcoma; Humans; Induction Chemotherapy; Magnetic Resonance Imaging; Positron-Emission Tomography; Prednisone; Skin; Transplantation, Autologous; Treatment Outcome; Vincristine | 2014 |
Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Cyclophosphamide; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Whole Body Imaging | 2015 |
The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prednisone; Prognosis; Radiotherapy; Retrospective Studies; Rituximab; Survival Analysis; Tumor Burden; Vincristine; Young Adult | 2015 |
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Boronic Acids; Bortezomib; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Prednisone; Pyrazines; Treatment Outcome; Vincristine | 2015 |
Utility of interim and end-of-treatment [(18)F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Prednisone; Proportional Hazards Models; Remission Induction; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Vincristine; Young Adult | 2015 |
Diffuse thyroid 18F-FDG uptake after R-CHOP therapy predicts favorable outcome in patients with DLBCL.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Rituximab; Thyroid Function Tests; Treatment Outcome; Vincristine; Young Adult | 2015 |
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; Rituximab; Salvage Therapy; Vincristine; Young Adult | 2015 |
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Rituximab; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2015 |
A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiotherapy; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Young Adult | 2016 |
Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Canada; Cyclophosphamide; Denmark; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Ovary; Pleura; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2015 |
Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Vincristine | 2016 |
[The prognosis value of early and interim ¹⁸F-FDG-PET/CT scans in patients with diffuse large B-cell lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Prognosis; Reproducibility of Results; Rituximab; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2015 |
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2016 |
Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient.
Topics: Aftercare; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Asymptomatic Diseases; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Fractures, Spontaneous; Giant Cell Arteritis; Humans; Humeral Fractures; Incidental Findings; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Male; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Subclavian Steal Syndrome; Temporal Arteries; Vincristine | 2016 |
The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2016 |
Disseminated Lymphoma Evolving into Neurolymphomatosis during Mid-cycle of Chemotherapy Detected by (18)F-FDG PET/CT.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Peripheral Nervous System Neoplasms; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Vincristine | 2015 |
Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Penile Neoplasms; Positron-Emission Tomography; Prednisone; Recurrence; Rituximab; Tomography, X-Ray Computed; Vincristine | 2016 |
Interim18 F-FLUORO-2-deoxy-d-glucose positron emission tomography scan/computed tomography scan in diffuse large B cell lymphoma-as a prognostic tool.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2016 |
Prognostic Role of Pre-Radiation Therapy (18)F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus Radiation.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2016 |
Malfunctioned cardiac resynchronization therapy attributed to acute exacerbation of cardiac sarcoidosis.
Topics: Adult; Cardiac Resynchronization Therapy; Cardiomyopathies; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Heart Failure; Humans; Male; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2016 |
Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Statistics as Topic; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2016 |
Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prednisone; Proportional Hazards Models; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rituximab; Time Factors; Treatment Outcome; Tumor Burden; Vincristine; Young Adult | 2016 |
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Leucovorin; Liver; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Rituximab; Statistics, Nonparametric; Vincristine; Young Adult | 2017 |
Mucosa-associated lymphoid tissue lymphoma with unusual
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Colectomy; Colon, Sigmoid; Colonoscopy; Colorectal Neoplasms; Cyclophosphamide; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Remission Induction; Rituximab; Sigmoid Neoplasms; Vincristine | 2017 |
Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?
Topics: Aged; Aged, 80 and over; Aorta; Carotid Arteries; Comorbidity; Female; Femoral Artery; Fluorodeoxyglucose F18; Follow-Up Studies; France; Giant Cell Arteritis; Glucocorticoids; Humans; Iliac Artery; Male; Middle Aged; Multicenter Studies as Topic; Outcome and Process Assessment, Health Care; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies | 2017 |
Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2016 |
Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Reference Values; Rituximab; Sensitivity and Specificity; Treatment Outcome; Vincristine | 2018 |
18F-FDG-PET/CT Pulmonary Infiltrates in Non-Hodgkin Lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Rituximab; Sex Factors; Tomography, X-Ray Computed; Vincristine | 2017 |
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Cell Transformation, Neoplastic; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Waldenstrom Macroglobulinemia | 2017 |
High 18F-fluorodeoxyglucose uptake in primary bilateral adrenal diffuse large B-cell lymphomas with nongerminal center B-cell phenotype: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Prednisone; Vincristine; Young Adult | 2018 |
Extreme hypercalcemia in a kidney transplant recipient.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Everolimus; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Hypercalcemia; Kidney Transplantation; Lymphoproliferative Disorders; Male; Positron-Emission Tomography; Prednisone; Renal Dialysis; Rituximab; Shock, Septic; Transplant Recipients; Vincristine | 2018 |
Extreme exigency in the extremity: an illustrative case of diffuse large B-cell lymphoma occurring in the arm.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Flow Cytometry; Fluorodeoxyglucose F18; Forearm; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine | 2018 |
Langerhans Cell Histiocytosis of Bilateral Mastoid Cavity.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cervical Vertebrae; Diagnosis, Differential; Ear Canal; Female; Fluorodeoxyglucose F18; Hearing Loss; Histiocytosis, Langerhans-Cell; Humans; Lost to Follow-Up; Lung; Mastoid; Middle Aged; Positron-Emission Tomography; Prednisone; Rare Diseases; Temporal Bone; Tomography, X-Ray Computed; Vinblastine | 2018 |
Paraneoplastic syndrome - a rare but treatable cause of non-thyroid-related extraocular muscle enlargement.
Topics: Aged; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Diplopia; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hypertrophy; Letrozole; Magnetic Resonance Imaging; Ocular Motility Disorders; Oculomotor Muscles; Paraneoplastic Syndromes; Piperazines; Positron-Emission Tomography; Prednisone; Pyridines | 2019 |
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Vincristine | 2019 |
18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Neoplasm Staging; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Vincristine | 2019 |
PET-derived tumor metrics predict DLBCL response and progression-free survival.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; ROC Curve; Treatment Outcome; Vincristine; Young Adult | 2019 |
Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-center experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Survival Analysis; Tumor Burden; Vincristine | 2021 |
Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Drug Therapy, Computer-Assisted; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Time Factors | 2019 |
Systemic sarcoidosis presenting as complete heart block in a patient with normal chest radiography.
Topics: Adult; Aftercare; Defibrillators, Implantable; Diagnosis, Differential; Echocardiography; Fluorodeoxyglucose F18; Glucocorticoids; Heart Block; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Prednisone; Rare Diseases; Sarcoidosis; Spleen; Treatment Outcome; Ventricular Dysfunction, Left | 2019 |
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Progression-Free Survival; Radiopharmaceuticals; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Time Factors; Vincristine; Watchful Waiting; Young Adult | 2019 |
Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Acinar Cell; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prednisone; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Triptorelin Pamoate; Vincristine | 2019 |
Role of interim and end of treatment positron emission tomography for response assessment and prediction of relapse in posttransplant lymphoproliferative disorder.
Topics: Adult; Aged; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Organ Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2019 |
Renal Pelvis Involvement of Immunoglobulin G4-Related Disease Mimicking Malignancy on 18F-FDG PET/CT.
Topics: Aged; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G4-Related Disease; Kidney Neoplasms; Kidney Pelvis; Positron Emission Tomography Computed Tomography; Prednisone | 2019 |
Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.
Topics: Adalimumab; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Cardiomyopathies; Deprescriptions; Drug Therapy, Combination; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sarcoidosis; Treatment Outcome | 2019 |
The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Propensity Score; Republic of Korea; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2020 |
[Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Vascular Neoplasms; Vincristine | 2019 |
Effect of Corticosteroid Dose and Duration on 18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis.
Topics: Adrenal Cortex Hormones; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Sarcoidosis; Time Factors; Treatment Outcome | 2020 |
Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Autografts; Bone Marrow; Chromosome Aberrations; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Rituximab; Survival Rate; Vincristine | 2020 |
Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT.
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lysine; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prostatic Neoplasms; Urea | 2020 |
Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Survival Analysis; Vincristine | 2020 |
Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy, Adjuvant; Radiotherapy, Image-Guided; Retrospective Studies; Rituximab; Single-Blind Method; Treatment Outcome; Tumor Burden; Vincristine; Young Adult | 2021 |
Prognostic value of 18F-fluorodeoxyglucose PET-CT score at baseline on the therapeutic response to prednisone in patients with polymyalgia rheumatica.
Topics: Fluorodeoxyglucose F18; Humans; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis | 2021 |
Case 285: Primary Breast Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast; Breast Neoplasms; Cyclophosphamide; Diagnostic Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Treatment Outcome; Ultrasonography, Mammary; Vincristine | 2021 |
Prognostic significance of bone marrow 2-[
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2021 |
Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Retrospective Studies; Rituximab; ROC Curve; Time Factors; Tumor Burden; Vincristine | 2021 |
Is it time for PET-guided therapy in follicular lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; COVID-19; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Outcome Assessment, Health Care; Pandemics; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Rituximab; SARS-CoV-2; Vincristine | 2022 |
Very delayed sinus arrest during complete remission of diffuse large B-cell lymphoma invading right atrium.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bradycardia; Cyclophosphamide; Doxorubicin; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Prednisone; Remission Induction; Rituximab; Sinus Arrest, Cardiac; Uterine Neoplasms; Vincristine | 2021 |
Analysis of the clinical manifestations and 18F-FDG PET-CT findings in 40 patients with histiocytic necrotizing lymphadenitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Female; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lymph Nodes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Retrospective Studies; Young Adult | 2021 |
End of treatment FDG-PET in primary mediastinal B-cell lymphoma treated with R-chemotherapy: Prognostic indicator and implications for consolidation radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Decision-Making; Combined Modality Therapy; Cyclophosphamide; Disease Management; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Retreatment; Rituximab; Treatment Outcome; Vincristine | 2022 |
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2022 |
Lymphoma presented as dysphagia: a diagnosis hard to swallow.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deglutition Disorders; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine | 2021 |
Prognostic significance of clinical characteristics and
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Vincristine; Young Adult | 2022 |
Evaluation of the Effects of R-CHOP Chemotherapy on Brain Glucose Metabolism in Patients with Diffuse Large B Cell Lymphoma: A Baseline, Interim, and End-of-Treatment PET/CT Study.
Topics: Antibodies, Monoclonal, Murine-Derived; Brain; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Glucose; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Tomography, X-Ray Computed; Vincristine | 2022 |
Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Immunosuppression Therapy; Male; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Sarcoidosis | 2022 |
Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Methotrexate; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2023 |
Treatment Resulting Changes in Volumes of High-
Topics: Adipose Tissue; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Orbit; Pericardium; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Vincristine | 2023 |
An International Survey of Current Clinical Practice in the Treatment of Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis | 2023 |
Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis.
Topics: Adalimumab; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Infliximab; Myocarditis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Tumor Necrosis Factor-alpha | 2023 |